Moreover, novel 5-gene signature-related to lipid metabolism including IMPHD1 can also be used as independent risk factor for bladder cancer patients (39), suggesting that IMPDH1-targeted agents might be useful in the treatment of tumors. This evidence concerns the gene IMPDH1 and urinary bladder carcinoma.